Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Mechanism of folding and assembly of a small tetrameric protein domain from tumor suppressor p53

Abstract

We have analyzed the folding pathway of the tetramerization domain of the tumor suppressor protein p53. Structures of transition states were determined from Φ–values for 25 mutations, including leucine to norvaline, and the analysis encompassed nearly every residue in the domain. Denatured monomers fold and dimerize, through a transition state with little native structure, to form a transient, highly structured dimeric intermediate. The intermediate dimerizes, through a native–like transition state with the primary dimers fully folded but with interdimer interactions only partially formed, to form the native tetramer as a 'dimer of dimers'.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Ribbon model of the p53tet structure.
Figure 2: a, Kinetics of unfolding of p53tetS in 4 M GdmCl followed by CD.
Figure 3: a, Kinetics of refolding of GdmCl–denatured p53tetS followed by CD.
Figure 4: Variation in the rate of unfolding with GdmCl concentration for some representative p53tet tetrameric mutants.
Figure 5: Residues with fractional Φ–values in analysis of p53tet unfolding.
Figure 6: Proposed qualitative reaction coordinate diagram for the folding and unfolding of tetrameric wild type p53tet and most tetrameric mutants.

Similar content being viewed by others

References

  1. Fersht, A.R., Matouschek, A. & Serrano, L. The folding of an enzyme. I. Theory of protein engineering analysis of stability and pathway of protein folding. J. Mol. Biol. 224, 771–782 ( 1992).

    Article  CAS  Google Scholar 

  2. Fersht, A.R. Characterizing transition states in protein folding: an essential step in the puzzle. Curr. Opin. Struct. Biol. 5, 79–84 (1994).

    Article  Google Scholar 

  3. Jaenicke, R. Folding and association of proteins. Prog. Biophys. Mol. Biol. 49, 117–237 ( 1987).

    Article  CAS  Google Scholar 

  4. Garel, J.–R. Folding of large proteins: multidomain and multisubunit proteins. In Protein Folding (ed. T.E. Creighton) 405–454 (Freeman, New York; 1992).

    Google Scholar 

  5. Price, N.C. Assembly of multi–subunit structures. In Mechanisms of protein folding. (ed. R.H. Pain) 160–193 (IRL Press, Oxford; 1994).

    Google Scholar 

  6. Neet, K.E. & Timm, D.E. Conformational stability of dimeric proteins: quantitative studies by equilibrium denaturation. Prot. Sci. 3, 2167–2174 ( 1994).

    Article  CAS  Google Scholar 

  7. Gittelman, M.S. & Matthews, C.R. Folding and stability of trp aporepressor from Escherichia coli. Biochemistry 29, 7011–7020 ( 1990).

    Article  CAS  Google Scholar 

  8. Milla, M.E. & Sauer, R.T. P22 Arc repressor: folding kinetics of a single– domain, dimeric protein. Biochemistry 33, 1125–1133 (1994).

    Article  CAS  Google Scholar 

  9. Wendt, H., Baici, A. & Bosshard, H.R. Mechanism of assembly of a leucine zipper domain. J. Am. Chem. Soc. 116, 6973– 6974 (1994).

    Article  CAS  Google Scholar 

  10. Wendt, H., Berger, C., Baici, A., Thomas, R.M. & Bosshard, H.R. Kinetics of folding of leucine zipper domains. Biochemistry 34, 4097–4107 (1995).

    Article  CAS  Google Scholar 

  11. Milla, M.E., Brown, B.M., Waldburger, C.D. & Sauer, R.T. P22 Arc repressor: transition state properties inferred from mutational effects on the rates of protein unfolding and refolding. Biochemistry 34, 13914–13919 (1995).

    Article  CAS  Google Scholar 

  12. Zitzewitz, J.A., Bilsel, O., Luo, J., Jones, B.E. & Matthews, C.R. Probing the folding mechanism of a leucine zipper peptide by stopped–flow circular dichroism spectroscopy. Biochemistry 34, 12812–12819 (1995).

    Article  CAS  Google Scholar 

  13. Mok, Y.–K., Bycroft, M. & dePrat–Gay, G. The dimeric DNA binding domain of the human papillomavirus E2 protein folds through a monomeric intermediate which cannot be native–like. Nature Struct. Biol. 3, 711– 717 (1996).

    Article  CAS  Google Scholar 

  14. Arrowsmith, C.H. & Morin, P. New insights into p53 function from structural studies. Oncogene 12, 1379–1385 (1996).

    CAS  PubMed  Google Scholar 

  15. Levine, A.J. p53, the cellular gatekeeper for growth and division. Cell 88, 323–331 (1997).

    Article  CAS  Google Scholar 

  16. Lee, W. et al. Solution structure of the tetrameric minimum transforming domain of p53. Nature Struct. Biol. 1, 877– 890 (1994).

    Article  CAS  Google Scholar 

  17. Clore, G.M. et al. Refined solution structure of the oligomerization domain of the tumor suppressor p53. Nature Struct. Biol. 2, 321–333 (1995).

    Article  CAS  Google Scholar 

  18. Jeffrey, P.D., Gorina, S. & Pavletich, N.P. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267, 1498–1502 (1995).

    Article  CAS  Google Scholar 

  19. Mateu, M.G. & Fersht, A.R. Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumor suppressor p53 tetramerization domain. EMBO J. 17, 2748–2758 (1998).

    Article  CAS  Google Scholar 

  20. Johnson, C.R., Morin, P.E., Arrowsmith, C.H. & Freire, E. Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor. Biochemistry 34, 5309–5316 (1995).

    Article  CAS  Google Scholar 

  21. Zaidi, F.N., Nath, U. & Udgaonkar, J.B. Multiple intermediates and transition states during protein unfolding. Nature Struct. Biol. 4,1016–1024 (1997).

    Article  CAS  Google Scholar 

  22. Jonsson, T., Waldburger, C.D. & Sauer, R.T. Nonlinear free energy relationships in Arc repressor unfolding imply the existence of unstable, native–like folding intermediates. Biochemistry 35, 4795– 4802 (1996).

    Article  CAS  Google Scholar 

  23. Tanford, C. Protein denaturation. Adv. Prot. Chem. 24, 1–95 (1970).

    CAS  Google Scholar 

  24. Muñoz, V. & Serrano, L. Elucidating the folding problem of helical peptides using empirical parameters. Nature Struct. Biol. 1, 399–409 (1994).

    Article  Google Scholar 

  25. McCoy, M. et al. Hydrophobic side–chain size is a determinant of the three– dimensional structure of the p53 oligomerization domain. EMBO J. 16, 6230–6236 ( 1997).

    Article  CAS  Google Scholar 

  26. Burton, R.E., Myers, J.K. & Oas, T.G. Protein folding dynamics: Quantitative comparison between theory and experiment. Biochemistry 37, 5337–534 (1998).

    Article  CAS  Google Scholar 

  27. Fersht, A.R. Nucleation Mechanisms in Protein Folding. Curr. Opin. Struct. Biol. 7, 3–9 (1997 ).

    Article  CAS  Google Scholar 

  28. Itzhaki, L.S., Otzen, D.E. & Fersht, A.R. The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: Evidence for a nucleation–condensation mechanism for protein folding J. Mol. Biol. 254, 260–288 (1995).

    Article  CAS  Google Scholar 

  29. Kraulis, P. J. Molscript: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946 –950 (1991).

    Article  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge M. Bycroft, C. Johnson and J.L. Neira for scientific discussions and expert advice. This work was supported by the CRC of the UK. M.G.M. was supported by a grant from the European Union.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alan R. Fersht.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mateu, M., Sánchez Del Pino, M. & Fersht, A. Mechanism of folding and assembly of a small tetrameric protein domain from tumor suppressor p53. Nat Struct Mol Biol 6, 191–198 (1999). https://doi.org/10.1038/5880

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/5880

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing